Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

2 Nov 2016 07:00

RNS Number : 0468O
Biome Technologies PLC
02 November 2016
 

[02 November 2016]

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Trading Update

 

Biome Technologies plc today publishes its trading update for the nine month period ended 30 September 2016.

 

Total Group revenues achieved in Q3 were £0.9m (2015: £1.3m). This takes Group revenues for the nine months to 30 September 2016 to £3.1m, 7% behind the prior year period (2015: £3.3m).

 

Net increase in cash and cash equivalents in the period was £0.2m taking the Group's cash position at 30 September 2016 to £1.2m (30 June 2016 £1.0m).

 

Bioplastics Division

 

Revenues in the Bioplastics division in Q3 were £0.3m (Q3 2015 £0.5m), resulting in revenues in the first nine months of the financial year being £0.9m (2015: £1.5m).

 

The Bioplastics division is developing a closely related suite of materials to enable coffee pod producers to sell biodegradable end products principally to the US consumer market. These comprise first, the outer packaging and the lid (now fully commercial); next, the ring of the pod; and lastly, the "non-woven" filter of the pod. The latter two materials are in the late stages of development.

 

The subdued turnover resulted principally from the timing of end market campaign runs of the commercialised packaging and lidding materials. Encouragingly, some £0.6m of orders have already been received for Q4.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies division in Q3 were £0.7m (Q3 2015: £0.8m), resulting in revenues in the first nine months of the financial year being £2.2m (2015: £1.9m).

 

The RF Technologies division sells a range of products using radio frequency technology, principally in the fibre optic market, and has been developing ways in which to expand this product portfolio into other market segments.

 

The order outlook in the fibre optic furnace market is strong and there are good signs of increased appetite for capacity investment in this sector.

 

 

 

Outlook

Group revenues for the second half of 2016 and the early part of 2017 will continue to reflect the volatility related to the new products of the Bioplastic division as they move from their development to commercialisation phases.

 

The Board expects Group revenues for the year to 31 December 2016 to be around the same level as those achieved in 2015.

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKDDNOBDDNDK
Date   Source Headline
11th Apr 20057:00 amRNSRe Agreement
7th Apr 20057:00 amRNSRe Agreement
6th Apr 200512:41 pmRNSAdditional Listing
24th Mar 20057:00 amRNSRe Contract
22nd Mar 20054:49 pmRNSAnnual Report and Accounts
21st Mar 20057:02 amRNSStatement on High Court
1st Mar 20057:01 amRNSUpdate re. trials with Asda
28th Feb 20057:00 amRNSFinal Results
23rd Feb 20054:45 pmRNSAdditional Listing
9th Feb 20053:16 pmRNSAgreement and Placing
8th Feb 20057:00 amRNSUpdate re. trials with Asda
31st Jan 20059:09 amRNSRe. Agreement
25th Jan 20057:00 amRNSDirectorate Change
17th Jan 200511:44 amRNSAdditional Listing
4th Jan 200511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.